Among adults with mild to severe obstructive sleep apnea, those receiving AD109, an oral combination drug, vs. placebo ...

Artificial Intelligence Among U.S. Hematology Oncology Fellows: A Multicenter Survey of Education, Attitudes, and Clinical Use Excess weight is a key modifiable risk factor for breast cancer. Glucagon ...

Research suggests that a waist-to-hip ratio (WHR) measurement is a better indicator of obesity than body mass index (BMI), ...

Adults with obesity achieved greater long-term weight loss if they partook in a nutrition plan designed for rapid weight loss ...

Lawmakers on Friday accused the Pentagon of gutting a congressionally mandated effort to reduce civilian harm after a new Inspector General investigation found the Defense Department had started ...

A weekly dose of semaglutide (2.4 mg) leads to a clinically significant reduction in body mass index (BMI) and related health outcomes in young adults with severe obesity who are treatment resistant ...

New research presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) shows that, following treatment for obesity or diabetes or both, using incretin-based drugs, losing ...

Fact checked by Jennifer Klump Key Takeaways The Medicare GLP-1 Bridge program will cover weight loss drugs for a $50 monthly copay for eligible beneficiaries through Dec. 31, 2027.Medicare currently ...

WASHINGTON — Homeland Security immigration leaders disagreed so vehemently over how to accomplish President Donald Trump’s goal of deporting 1 million people during his first year back in office that ...